BASIC LEVEL COURSES
October 24-26, 2025
Friday, October 24, 2025, 8:00 AM – 5:00 PM
1. BSL-3 Operations and Management
This course will review the important aspects of BSL-3 Operations and Management from two points of view; “hardware” (i.e., facilities & equipment issues) and “software” (i.e., administrative controls). It will cover various aspects you need to consider in order to operate a BSL-3 facility, such as training, maintenance support, occupational health, waste management, maintenance, performance verification, and emergency response. The instructors will encourage interaction and the exchange of experiences among the attendees. Regulatory aspects from any specific country, or planning, design, or construction-related issues will not be covered.
Objectives:
- Describe the elements of BSL-3 Operations and Management (risk management, primary barriers, annual performance verification, emergency response, etc)
- Recognize institutional, management, and user responsibilities
- Summarize approaches to developing manuals, SOPs, and training
Suggested Background: Basic Risk Assessment and familiarity with BSL-3 Concepts
Target Audience: Safety Professionals, BSL-3 Managers, Containment Engineers, Lab and Scientific Directors
Audience Level: Basic
COURSE FACULTY
J. Paul Jennette, MS, PE, RBP(ABSA), CBSP(ABSA)
Biosafety Engineer
Director of Biocontainment Operations
Cornell College of Veterinary Medicine
Ithaca, NY
Paul Jennette holds Bachelor’s and Master’s Degrees in Environmental Engineering from Cornell and the University of Massachusetts, respectively, and is both a Registered Professional Engineer and a Certified Biological Safety Professional. Since 1999, he has held the position of Biosafety Engineer at the Cornell College of Veterinary Medicine and has also been the Director of Biocontainment Operations there since 2013. Paul’s responsibilities include: design, verification, operation, decontamination, and program management related to Cornell’s BSL-3, ACL-3, and ABSL-3 facilities, which include both research & diagnostic laboratories as well as a BSL-3 large animal necropsy; training all Cornell BSL-3 scientific and support staff and providing direct, in-containment support for BSL-3 diagnostic operations; directing the operations of Cornell’s medical and pathological waste treatment facility, which includes a 5,000-lb/batch carcass digester; serving on Cornell’s Institutional Biosafety Committee and directing the Cornell Vet College Rabies Risk Management Program. Paul serves on biosecurity teams for Select Agent Labs at the Cornell Vet College and provides technical support for the College’s effluent decontamination systems. He served as the American Biological Safety Association’s representative on the ANSI committee to develop a national standard for the verification of BSL-3 facility performance, is a reviewer and lead author of a technical column for the Applied Biosafety journal, and is a member of ABSA’s Professional Development Team. He is a former co-chair of ABSA’s Principles & Practices of Biosafety class as well as a regular instructor for BSL-3 courses offered by the Eagleson Institute and ABSA. In addition to his position at Cornell, Paul provides biocontainment operations consulting services to a variety of academic, governmental, and pharmaceutical clients.
Carrie Smith has served as a biosafety professional for over fourteen years in academia, the government, and the private sector. In her current role, she serves as a Senior Scientist with Merrick & Company, specializing in biosafety and laboratory operations planning for new laboratories, renovations, and laboratory transitions. Prior to her role at Merrick, she served as BSO and ARO at Oklahoma State University, a biosafety specialist and trainer at University of Wisconsin—Madison, and BSO and ARO at the USGS National Wildlife Health Center. Carrie earned her undergraduate degree in Biology with a concentration in Biotechnology from the University of Delaware and her PhD in Genetics from North Carolina State University. Her research included work with recombinant bacteria, viruses, fungi, and plants as well as biological toxins. As a biosafety professional, Carrie has managed both small and large biosafety programs and her expertise includes BSL-3/ABSL-3 oversight, atypical animals in biocontainment, select agent program management, recombinant technology, plant biosafety, diagnostic labs, and on-line and in-person training development. She serves as Co-Chair and Instructor for ABSA’s Principles & Practices of Biosafety Course and is a member of the Preconference Course Committee.
Dee Zimmerman retired from the University of Texas Medical Branch, Environmental Health and Safety. She was the university biosafety officer, director of the health, safety and training core for the University of Texas Medical Branch—Galveston (UTMB) National Laboratory, senior environmental health and safety consultant in the Biological Safety program and served as the university’s select agent program alternate responsible official, IBC member and coordinator. Her duties include working closely with research staff in BSL-2, BSL-3, BSL-4, ABSL-2, 3, and 4 laboratories working closely with research scientists, biocontainment engineers, facility staff and occupational health. Dee was with the University of Texas Medical Branch from 1982 until retiring in 2017. She attended Inter-American University in Puerto Rico and was the lab and safety coordinator for the Marine Ecology Division, Center for Energy and Environmental Research at the University of Puerto Rico. Dee is the 2019 Past President of ABSA International.
CONTACT HOURS
This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.
Friday, October 24, 2025, 8:00 AM – 5:00 PM
2. Infectious Substance Shipping Certification
This course is appropriate for those who have some experience with infectious substance handling or shipping but may not have been certified within the past three years. The course utilizes several facilitated learning activities. Attendees have opportunities to mark, label, package and complete documentation for a variety of infectious substances shipments (Category A, Category B, Exempt Patient Specimens). This course would be appropriate for those responsible for packaging, marking, labeling shipments of all categories of infectious substances, dry ice and liquid nitrogen. Attendees have both an online exam (score at least 80%) and practical exercises to complete to demonstrate competency. Successful completion of the course will qualify attendees for IATA/DOT certification.
Objectives:
- Demonstrate competency to meet IATA infectious substance shipping certification requirements
- Restate and demonstrate how to properly package, mark/label, document and prepare shipments of category A and B infectious substances and other non-regulated biological materials
- Paraphrase any regulatory changes over the past several years and apply them to meet regulatory re-training requirements
Suggested Background: None
Target Audience: All Safety Professionals, New Biosafety Professionals, Laboratory Workers
Audience Level: Basic
COURSE FACULTY
Eric Cook, MPH
Senior Member – Technical Staff
Sandia National Laboratories
Albuquerque, NM
Eric Cook is a Senior Member of the Technical Staff in the International Biological and Chemical Threat Reduction Program at Sandia National Laboratories where his work focuses on promoting global laboratory biorisk management. He serves as one of the program’s lead trainers. Eric served as the Biosafety Officer for Dartmouth College in Hanover, NH for five years where he managed the Biosafety Program and Institutional Biosafety Committee. Prior to working at Dartmouth, Eric was an Assistant Biosafety Officer at the Massachusetts Institute of Technology for six years. While at MIT, Eric completed his Master’s Degree in Public Health at Boston University with a focus on Environmental Health. Eric has a B.S.in Molecular Biology from Brigham Young University where he worked in a recombinant DNA lab for two years assisting with work in phylogenetics. He is certified by the National Registry of Certified Microbiologists as a Specialist Microbiologist in Biological Safety Microbiology and previously by ABSA International as a Certified Biological Safety Professional. Eric has particular expertise in dangerous goods and infectious substance shipping. He worked for three years at Saf-T-Pak, Inc. developing training programs and packaging for shipping infectious substances.
CONTACT HOURS
This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.
Friday, October 24, 2025, 8:00 AM – 5:00 PM
3. Preparing for and Responding to Laboratory Emergencies – Are you prepared?
Biosafety professionals often provide fundamental training for research and healthcare staff to work safely and respond to potential emergencies involving a wide range of biological hazards. Training employees to proactively identify and take appropriate actions to minimize the likelihood and impact of these types of incidents helps to minimize the development of serious and/or irreversible consequences. This course reviews the process for developing an effective emergency response plan, emphasizing the importance of a comprehensive and well-coordinated training program for laboratory staff, institutional incident response team members, and local first responders (e.g., emergency management services, fire, police, emergency dispatchers) when biological hazards are involved. Specific topics to be addressed include: the basic components of a comprehensive institutional emergency response plan; laboratory-specific contingency plans, emphasizing unique considerations for emergencies that involve biological hazards; staff roles and responsibilities during emergencies; communication strategies and protocols during an emergency event; and training and effective preparedness exercises to ensure a coordinated response effort.
Objectives:
- Review key components of the emergency management cycle as it applies to research institutions and laboratories
- Identify the various roles and responsibilities that are critical to an effective response
- Summarize ways to coordinate and communicate effectively with institutional and local authorities during an emergency
Suggested Background: Biosafety and Biosecurity Training Course (BBTC®), Fundamentals of Biosafety
Target Audience: All Safety Professionals, Laboratory Workers, New Biosafety Professionals
Audience Level: Basic
COURSE FACULTY
Susan Harper, DVM, MS, DACLAM, DACVPM, RBP (ABSA)
Private Consultant
Shepherdstown, WV
Dr. Susan Harper received her DVM from Louisiana State University and worked in large animal practice for several years before enrolling in a post-doctoral residency in comparative medicine at the Penn State University College of Medicine. She served on the Penn State faculty for 2 years following graduation, before accepting a position with the National Institutes of Health (NIH). She has worked at several different Departments and Agencies during her federal career and currently serves as the Deputy Director for the NIH Office of Animal Care and Use in Bethesda, MD. She is a diplomate of the American College of Laboratory Animal Medicine (ACLAM) and the American College of Veterinary Preventative Medicine (ACVPM); a Registered Biosafety Professional (RBP) through ABSA International; and serves on the AAALAC International Council on Accreditation.
Deborah Howard, MPH, CBSP(ABSA)
Global Environment, Health, and Safety Biological Materials Manager
BASF
Durham, NC
Deborah Howard is the Expert, Global Environment, Health & Safety Biological Materials Manager for BASF where she has oversight of greenhouses, laboratories, inoculant, & fermentation sites. She has been the Biosafety Manager at BASF since May 2014. Deborah has extensive experience with IBC’s, IACUC, Select Agent regulations, exporting, greenhouse, arthropods, genetically modified plants, & animals. She has over 30 years of experience in health and safety & knowledge of regulations including NIH, OSHA, EPA, APHIS, & USDA. Previously, she was the Biosafety Manager at UNC Chapel Hill where she was the IBC Administrator for 6 years.
Anita Harrell has 10 years of experience in the fields of Occupational Safety, Biological Safety and Laboratory Safety. She has worked at BASF for 35 years and is currently the North America Biosafety Manager. Prior to joining BASF, Anita worked at North Carolina State University in Raleigh, NC. She received a degree in Botany from NCSU in 1983. Anita currently oversees the North American Biological Safety Programs. She works with site biosafety representatives to oversee these areas. She participates and several global biosafety teams at BASF.
CONTACT HOURS
This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.
Saturday, October 25, 2025, 8:00 AM – 5:00 PM
5. Facilities Fundamentals for Biosafety Professionals
This course is aimed at strengthening biosafety professionals knowledge of how facility operations support overall biocontainment operations. Through a mixture of presentations from experts in the field and interactive exercises, attendees will reinforce their knowledge of facility system function and their roles in facility design, construction, and operation. The target audience for the course is biosafety professionals who come with backgrounds other than facilities, and it is open to both newcomers and seasoned veterans in the field. The first portion of the course will familiarize attendees with the general concepts biosafety-related facility design and their roles in it, along with the fundamentals of HVAC system operation in the context of BSL-2 and BSL-3 facilities. Topics in this portion of the course include: the role of biosafety personnel in biocontainment facility design, renovation, and operations, understanding design drawings and related construction documents, what the relationship is of facility features to biosafety levels, and HVAC components and their function relative to biocontainment. This section will end with the introduction of an interactive exercise on reviewing design drawings. The instructors will lead interactive exercises and discussions of more detailed aspects of containment facilities and their operation, including: specific infrastructure, equipment, and systems related to operation of a biocontainment facility; autoclave function, waste management, associated facility infrastructure; room decontamination in relation to facility components; interactions between facilities and containment equipment; security, operations, and biosafety.
Objectives:
- Restate the roles of biosafety professionals in facility design and operation
- Explain practical approaches for reviewing design documents.
- Describe the function of discrete facility infrastructure, equipment, and systems related to biocontainment facility operations
Suggested Background: Fundamentals of Biosafety, Principles and Practices of Biosafety® (PPB), Risk Assessment
Target Audience: All Biosafety Professionals, All Safety Professionals
Audience Level: Basic
COURSE FACULTY
J. Paul Jennette, MS, PE, RBP(ABSA), CBSP(ABSA)
Biosafety Engineer
Director of Biocontainment Operations
Cornell College of Veterinary Medicine
Ithaca, NY
Paul Jennette holds Bachelor’s and Master’s Degrees in Environmental Engineering from Cornell and the University of Massachusetts, respectively, and is both a Registered Professional Engineer and a Certified Biological Safety Professional. Since 1999, he has held the position of Biosafety Engineer at the Cornell College of Veterinary Medicine and has also been the Director of Biocontainment Operations there since 2013. Paul’s responsibilities include: design, verification, operation, decontamination, and program management related to Cornell’s BSL-3, ACL-3, and ABSL-3 facilities, which include both research & diagnostic laboratories as well as a BSL-3 large animal necropsy; training all Cornell BSL-3 scientific and support staff and providing direct, in-containment support for BSL-3 diagnostic operations; directing the operations of Cornell’s medical and pathological waste treatment facility, which includes a 5,000-lb/batch carcass digester; serving on Cornell’s Institutional Biosafety Committee and directing the Cornell Vet College Rabies Risk Management Program. Paul serves on biosecurity teams for Select Agent Labs at the Cornell Vet College and provides technical support for the College’s effluent decontamination systems. He served as the American Biological Safety Association’s representative on the ANSI committee to develop a national standard for the verification of BSL-3 facility performance, is a reviewer and lead author of a technical column for the Applied Biosafety journal, and is a member of ABSA’s Professional Development Team. He is a former co-chair of ABSA’s Principles & Practices of Biosafety class as well as a regular instructor for BSL-3 courses offered by the Eagleson Institute and ABSA. In addition to his position at Cornell, Paul provides biocontainment operations consulting services to a variety of academic, governmental, and pharmaceutical clients.
Stephen Helgren is a Senior Architect and Laboratory Planner for Merrick & Company, with over 24 years of diversified experience in complex life science facilities and extensive expertise in laboratory programming, planning, design, and construction. He has experience with BSL-3 facilities for private companies, public universities, the USDA, and Canadian clients.
Fahim Manzur is a Senior Commissioning Specialist within the Life Sciences Commissioning Group at Merrick and Company. Fahim has 16+ years of experience in facility engineering, facility/laboratory operations and maintenance, laboratory/equipment commissioning and decommissioning, biological safety, and select agent regulatory compliance at high-containment biological laboratories. Notable work includes projects for USDA, DHS, and Mexico (University and Federal) biocontainment facilities. Prior to joining Merrick, Fahim worked as a consultant and operations & maintenance biological compliance engineering supervisor for the Plum Island Animal Disease Center (PIADC) for over 13 years. While at PIADC, Fahim oversaw facilities upgrades, supported biocontainment construction and commissioning projects, led decontamination and decommissioning efforts for containment spaces, and managed the effluent decontamination system building. Fahim is currently primarily providing support for PIADC terminal decontamination and decommissioning efforts at PIADC with Merrick. He holds a Masters in Biomedical Engineering from the University of Connecticut and is a Registered Biosafety Professional (RBP) through ABSA. Fahim has been a member of ABSA since 2009 and has participated in multiple conferences through poster sessions and platform presentations over the years.
CONTACT HOURS
This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.
Saturday, October 25, 2025, 8:00 AM – 5:00 PM
6. Beginners’ Guide to Comprehensive Biorisk Management: Integrating Biosafety and Biosecurity Practices
This course provides attendees with a comprehensive foundation in biorisk management by integrating biosafety and biosecurity principles within a unified risk assessment framework. Centered around the AMP (Assessment, Mitigation, Performance) model, the course delivers practical tools for identifying, evaluating, and mitigating risks associated with the handling of biological agents and toxins. Attendees will gain a solid understanding of biosafety and biosecurity risk assessments and learn how to apply core assessment strategies effectively. Through a dynamic mix of lectures, real-world case studies, and hands-on group exercises, attendees will explore both foundational and emerging issues in biorisk management. The course emphasizes actionable strategies that can be tailored to diverse institutional environments and translated into improved safety and security practices. Attendees will conclude the course with enhanced awareness of complex biorisk scenarios and the skills to implement risk-informed mitigation measures within their own organizations.
Objectives:
- Describe the AMP model of biorisk management and utilize it to address biological risks
- Develop and implement effective risk mitigation strategies including engineering controls, administrative controls, work practices, and personal protective equipment
- Summarize how the five pillars of biosecurity support biorisk programs, inform performance evaluation and stakeholder engagement to stregthen safety culture
Suggested Background: Micro/Molecular Biology 101
Target Audience: New Biosafety Professionals, All Safety Professionals
Audience Level: Basic
COURSE FACULTY
Dr. Antony Schwartz is the Director of Biological Safety at Duke University, where he serves as the Institutional Biosafety Officer, Responsible Official for the Select Agent Program, and Institutional Contact for Dual Use Research (ICDUR). In these roles, he ensures institutional compliance with federal regulations governing biosafety, biosecurity, and dual-use research oversight. He also holds an appointment as an Adjunct Assistant Professor in the Department of Family Medicine and Community Health at the Duke University School of Medicine. Dr. Schwartz and his team oversee biological hazards across research laboratories and healthcare settings, including the Duke Regional Biocontainment Laboratory (RBL), clinical trials and microbiology labs, autopsy and gross anatomy labs, phytotrons, and arthropod containment facilities. His oversight spans BSL-1 through BSL-3/ABSL-3 spaces, including BSL-2+ and ABSL-2 environments. Prior to Duke, Dr. Schwartz was the Responsible Official for the National Institutes of Health Select Agent Program in Bethesda, Maryland. He was previously a postdoctoral fellow in the National Biosafety and Biocontainment Training Program (NBBTP), a competitive, in-residence fellowship at NIH designed to prepare professionals to manage BSL-3 and BSL-4 laboratories handling high-risk pathogens such as Ebola, Monkeypox, and Nipah virus. He has also served as a BSL-4 instructor and course facilitator at NIH and NIAID facilities. Dr. Schwartz holds a PhD in Microbiology with a minor in Technology Commercialization. A Certified Biological Safety Professional (CBSP) through ABSA International, Dr. Schwartz has held numerous leadership roles in the organization, including Councilor, Chair of the Pre-Conference Course Committee, Vice Team Lead for the Regulatory and Technical Affairs Team, Journal Board Reviewer, and Co-Chair of the inaugural Biosecurity Symposium Steering Committee. He remains actively engaged in biosafety and biosecurity through research, publications, professional outreach, and mentorship.
Dr. Andrea Vogel is currently a Safety and Health Specialist in the Biological Safety Division of the Occupational and Environmental Safety Office at Duke University Health Systems. She is also an Alternate Responsible Official for the Select Agent Program. The Biological Safety Division oversees programs implemented for mitigating biological hazards at Duke University, Duke University Hospital and Clinics. Programs she oversees include the Bloodborne Pathogens Exposure Control Program, Tuberculosis Control Program, and the BSL-3 Laboratory Program. Dr. Vogel has been a member of ABSA International since 2021 and is an active member of the Journal Board, Finance Committee, Awards Committee, and Pre-Conference Course Committee. Her interests include biosafety/biosecurity program management, risk assessment of emerging infectious diseases and technologies, and application of technology to enhance understanding in training programs. Dr. Vogel received her PhD in Genetics from North Carolina State University, and was a NIH NBBTP Fellow. She has authored several papers ranging from validation of hydrogen peroxide vapor to facilitate re-use of N95s to animal behavior and group coordination.
CONTACT HOURS
This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.
Saturday, October 25, 2025, 8:00 AM – 5:00 PM
7. Engineering for the Biosafety Professional Part 2
Proactive biosafety professionals need to be involved and knowledgeable in the operation, maintenance and certification of their containment facilities and building systems. Frequently, the biosafety professional is called upon to participate in the planning, design, and validation of a new biocontainment laboratory or renovation of an existing facility. For the biosafety professional to participate in these activities, they need a foundation of engineering fundamentals, develop skills to ask questions in engineering terms, and have the confidence to question the answers. This course provides engineering principles that are useful in the planning, design, construction, maintenance and operation of a BSL-3 or high containment facility. The principles are expanded to BSL-4 or maximum containment facilities for clarity between BSL-3 and BSL-4 requirements. The information covered in this course is specific to NIH, CDC, and BMBL 6th ed. requirements.
Objectives:
- Discuss engineering principles
- Apply engineering assessment tools for architectural and engineering drawings
- Implement engineering solutions
Suggested Background: None
Target Audience: All Safety Professionals, Operations and Maintenance Staff
Audience Level: Basic
COURSE FACULTY
Juan Osorio provides consulting in engineering with a focus in high and maximum containment laboratories (BSL-3 and BSL-4), biomedical facilities, hospitals and research facilities. In this role, he consults with clients regarding laboratory planning, programming, commissioning, validation and third party certification activities for significant biocontainment, laboratory, vivarium, safety and healthcare projects. Mr. Osorio has consulted, reviewed, validated, and certified biocontainment laboratories, mission critical government institutions, vivaria, and world-class medical facilities. He has vast experience in the high- and maximum containment fields and participates on biocontainment projects in the United States, Asia, and South America. Mr. Osorio contributes to the design, construction, validation, third-party certification, and maintenance of such facilities. He has served frequently as a consultant for the National Institutes of Health (NIH) and the U.S. Food and Drug Administration (FDA) for industrial engineering issues in biocontainment, general laboratory, hospital, and vivarium projects. He has assisted in the development of high- and maximum containment government guidelines and regulations for the NIH.
Theodore (Ted) Traum has over thirty years of experience in engineering with a focus in high- and maximum containment laboratories (BSL-3 and BSL-4), biomedical facilities, hospitals and researchfacilities. In this role, he consults with clients and oversees laboratory planning, programming, commissioning, validation, and third-party certification activities for significant biocontainment, laboratory, vivarium, safety and healthcare projects. Following the September 11, 2001 attacks, Mr. Traum received a considerable influx of biosafety and biocontainment projects to combat bioterrorism. Capitalizing on his niche expertise in this fast growing industry and its previous work with the JCAHO statement of conditions, Mr. Traum focused his business development efforts towards developing acertification program for biocontainment laboratories, their design, construction, operation, biosafety consultation, and maintenance through World BioHazTec (WBHT). Being one of the only few firms in the United States with a significant level of expertise and previous success in niche projects for the healthcare and research laboratories, Mr. Traum became sought after nationally and internationally as the premier consultant for oversight, management, and certification of biocontainment facilities. Mr. Traum has consulted, reviewed, validated, and certified biocontainment laboratories, mission critical government institutions, vivaria, and world-class medical facilities. He is a highly respected professional engineer in the high- and maximum containment field and is sought worldwide for his experienceand expertise in design, construction, third-party certification, and maintenance of such facilities. He has served frequently as a consultant for the National Institutes of Health (NIH) and the U.S. Food and Drug Administration for HVAC, mechanical, and industrial engineering issues in biocontainment, general laboratory, hospital, and vivarium projects.
CONTACT HOURS
This course has been approved for 1.0 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 7.5 P.A.C.E.® contact hours.
Saturday, October 25, 2025, 8:00 AM – 12:00 PM
9. Nanoparticles in Modern Science—Understanding Hazards, Controls, and Safe Practices
Nanotechnology is revolutionizing many areas of modern life, offering innovative solutions across medicine, science, engineering, and technology. Nanoparticles (NPs), with their unique properties, are defined by composition, size, shape, and surface characteristics, hold significant promise in these fields. However, these same properties present challenges in recognizing, evaluating, and mitigating potential environmental, health, and safety risks associated with the production and application of nanoparticles. This course introduces the types, properties, production and synthesis of nanoparticles, focusing on their interactions with biological systems and associated chemicals, as well as potential implications of radiolabeled nanoparticles. This understanding is crucial for developing effective risk assessment and mitigation strategies for both in-vivo and in-vitro applications. It covers biosafety, biosecurity, and occupational health risks, emphasizing hazard identification, control measures, and knowledge gaps in nanotechnology. Through case studies and interactive exercises, attendees will explore best practices for safe handling, waste management, exposure assessment, and transport of nanoparticles. These hands-on activities will reinforce key concepts, fostering peer learning and collaboration.
Objectives:
- Identify common types of nanoparticles and their key properties
- Evaluate potential risks and safety concerns associated with the production and use of nanoparticles, including occupational exposure and environmental impacts.
- Develop and implement effective risk management strategies for laboratory projects involving nanoparticles, including hazard identification, exposure controls, and best practices for safe handling, waste disposal, and transport
Suggested Background: None
Target Audience: All Safety Professionals, Laboratory Workers, Animal Caretakers
Audience Level: Basic
COURSE FACULTY
Dr. Maya Nair is the Director of Biological Safety at the University of North Texas Health Science Center (UNTHSC) in Fort Worth, Texas, where she also serves as the Biosafety and Assistant Radiation Safety Officer. In this capacity, she oversees a broad range of safety programs, including biosafety, radiation safety, DEA-controlled substances, animal safety, laser safety, and risk management.Dr. Nair has been instrumental in establishing and leading the UNTHSC Biosafety Program and has served as the Biosafety Officer for the past 18 years. She has also held the role of Reviewing Official for the institution’s Increased Control Program. With over 25 years of experience in biomedical research, Dr. Nair’s scientific background is focused on nanoparticle-based targeted drug delivery systems for cancer therapy. She has presented her research at numerous national and international conferences and has authored several peer-reviewed publications and book chapters on the application of nanoparticles in the biomedical field.In addition to her scientific contributions, Dr. Nair is passionate about education and training. She has developed and taught graduate-level safety courses for public health students and has mentored many students in the field of Environmental Health and Safety. She is an active member of UNTHSC’s Institutional Compliance Group, contributing to policy development and review, and collaborates with key committees such as the Institutional Animal Care and Use Committee (IACUC) and Institutional Review Board (IRB). Dr. Nair also serves as an external reviewer for Institutional Biosafety Committees (IBCs) at other institutions.Dr. Nair has been an active member of the American Biological Safety Association (ABSA) International since 2007, serving on various committees and task force. She served as the Chair of the Training Tools Committee for 2020-2025. She is also a member of the Southern Biosafety Association. Her professional interests include the effective management of comprehensive safety programs and exploring the impact of emerging technologies on safety and security.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.
Saturday, October 25, 2025, 8:00 AM – 12:00 PM
10. The Big Bright Beautiful World of BSL-2
Ever wondered why handling human blood samples and culturing infectious influenza both require BSL-2 containment? Or the defining characteristics between BSL-2 and BSL-1 or BSL-3? This course transforms biosafety from a checklist into a strategic risk management framework, adaptable to any facility or resource level. We’ll go beyond textbook scenarios, tackling the gray areas of BSL-2 where critical thinking and adaptability are key. Starting with a rapid refresher on core biosafety principles, we’ll explore how to adjust BSL-2 containment ‘levers’ for real-world applications, even in non-ideal or resource-limited labs. This course isn’t just about following rules—it’s about understanding why they exist. Attendees will explore key topics in biosafety, including distinctions and special considerations of BSL-2 and ABSL-2, the critical difference between regulations and recommendations on lab operations, compare global biosafety guidelines with the BMBL, safe handling of RG-3 agents in BSL-2 settings, emerging BSL-2+ practices, and real-world case studies—such as HIV and SARS-CoV-2—through interactive activities. This course empowers new biosafety professionals to move beyond a rigid, one-size-fits-all approach. Attendees will develop the confidence to make informed, customized containment decisions—becoming strategic biosafety leaders in their field.
Objectives:
- Utilize the BMBL as a framework and move beyond a checklist approach and apply adaptive biosafety practices in diverse laboratory settings, including resource-limited or non-ideal facilities
- Explain BSL-2 containment principles and practices and how this relates to “BSL-2+” containment and allows for the handling of Risk Group 3 agents under BSL-2 conditions
- Adapt the foundation necessary to confidently make non-textbook containment recommendations that will meet BSL-2 recommendations and keep researchers safe
Suggested Background: None
Target Audience: New Biosafety Professionals, All Safety Professionals, Animal Caretakers
Audience Level: Basic
COURSE FACULTY
Heidi has extensive experience in, and passion for, the ‘grey zone’, intertwining regulation, safety and human behavior to find the best overall solutions to the safety and compliance challenges we face when doing research. Heidi has 15+ years of experience in the field of biosafety and has over 7 years of experience serving as the Biological Safety Officer and Assistant Director of Environmental Health and Safety at Case Western Reserve University. She earned a BS in Organismal Biology from the University of Kansas, a MS in Cell and Molecular biology from University of Missouri—Kansas City and is a Registered Biosafety Professional with ABSA International. In her role as the Director of Sabai’s Shield Consulting group, Heidi has the opportunity to work with varied clients from academic institutions, CROs, startup biotechs, large pharma, and healthcare institutions. Outside of work Heidi is often found trying her hand at something new, be it gardening, cooking, raising chickens or keeping bees. She feels passionately that there is always something new to learn.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.
Saturday, October 25, 2025, 1:00 PM – 5:00 PM
11. Writing Effective Standard Operating Procedures
This course will offer attendees an understanding of key principles for writing effective standard operating procedures (SOPs). An introduction to the importance of SOPs in achieving desirable and consistent outcomes and issues that must be considered in the SOP writing process will be presented. Examples will include some of the most common human behavior considerations such as compliance, behavioral evolution, complaisance, and strategies to address behavioral concerns that may arise. Attendees will engage in guided discussions about the benefits of an effective SOP writing process and the most common mistakes made by the authors of SOPs. The course will take attendees through the process of writing feasible standard operating procedures (SOPs) including SOP evaluation and validation. Through group interactions, attendees will develop examples of SOPs to illustrate effective writing concepts, present their SOPs to the class, and evaluate each other’s SOPs for feasibility. Instructors will guide attendees through the process by providing critical feedback on the SOP writing process as they progress. The goal of this course is to increase attendees’ awareness of issues that arise when writing standard operating procedures and how these issues affect SOP compliance. Furthermore, the course will provide examples of well-written SOPs that contribute to overall SOP compliance at an institution. The course is intended for those who want to be able to lead or aid in the creation of feasible and effective SOPs in order to enhance both biosafety and biosecurity at their institution.
Objectives:
- Summarize the range of issues that must be considered when writing effective standard operating procedures (SOPs), including human behavior
- Identify strategies for writing effective SOPs
- Illustrate how good standard operating procedures (SOPs) work to enhance both biosafety and biosecurity
- Recognize the value of “feasible” and therefore effective standard operating procedure (SOP) in promoting biosafety and biosecurity best practices
Suggested Background: Fundamentals of Biosafety
Target Audience: All Safety Professionals, New Biosafety Professionals, Laboratory Workers, International Attendees
Audience Level: Basic
COURSE FACULTY
Natasha Griffith is the CEO of SOTER Bio Consulting, where she leads different national and international projects in response to health emergencies. She also serves as Associate Director, High Containment Core at Georgia State University (GSU) where she leads a multidisciplinary team to support safe operations and maintenance (O&M) of all high-containment facilities (BSL-3, ABSL-3, and BSL-4) at GSU. Natasha earned her Master of Science degree in Microbial Pathogenesis and a Bachelor of Science degree in Microbiology, Immunology and Molecular Genetics from UCLA as well as Master of Public Health in Paris, France. With over 20 years of experience, Natasha has led numerous international missions in response to infectious disease outbreaks. Before joining GSU, Natasha was the Branch Chief of Quality and Safety Systems, DLS, CSELS at the CDC where she led quality and safety staff to support the development of standards, guidelines, recommendations, and tools for improved quality and safety in clinical and public health laboratories. While at the CDC, Natasha also implemented and managed international projects in response to outbreaks of infectious diseases in various countries. These projects included development of program initiatives for a variety of local, national and international public health institutions in both English and French. Prior to her work at CDC, Natasha established and operated a state-of-art Tier 1 Select Agent high-containment program at UCLA. For over a decade, Natasha directed all high-contaminant facilities and served as the Responsible Official (CDC DSAT) for all select agent research at the University of California, Los Angeles (UCLA).
William (Bill) Arndt is Senior Biosafety Officer (BSO) at Georgia State University where he oversees biosafety and biosecurity for the GSU research community and leads a multidisciplinary team to support safe research at GSU. Bill earned his Doctor of Philosophy (PhD) degree in Microbiology from Arizona State University and a Bachelor of Science degree in Microbiology from South Dakota State University. Bill is virologist by training and subject matter expert in areas of disease surveillance, infectious disease diagnostics, incident/outbreak response, vaccine development/production, high-containment laboratory operations, biorisk management, and dual-use research of concern (DURC). He has supported the US Government health security and capacity building initiatives for 12+ years across Africa, Middle East, and Southeast Asia. Before joining GSU, Bill was a Biosafety Team Lead and International Program Lead in the Division of Laboratory Systems (DLS), CSELS at the CDC where he was responsible for managing multi-member teams and projects related to providing support to public health and clinical laboratories and development of national biosafety and biosecurity legislation, policies, regulations, and guidelines development. Prior to his work at CDC, Bill was a Principal Member of the Technical Staff at Sandia national Laboratories where he led various activities related to laboratory design best practices and outbreak response.
Dr. Asadulghani has been working in the field laboratory systems strengthening using One Health platform in Bangladesh since 2010, with 14 years’ experience of research in the field of Molecular Genetics and Bacteriophage Biology, at home and abroad, since 1993. He has an MSc and MPhil in the field of Molecular Genetics, from the University of Dhaka. He has a PhD, in the field of post-transcriptional regulation of genes expression, from the Saitama University, Japan in 2004. Completing his postdoctoral research as a Research Associate and JSPS Postdoc Fellow, at the University of Miyazaki, Japan, he joined as an Assistant Professor in the Division of Microbiology and continued working in the Microbial Whole Genome Sequencing Group, Japan. Since September 2009, he has been working as the Head of Biosafety, leading biosafety and biosecurity program, at the International Centre of Diarrhoeal Disease Research, Bangladesh (ICDDR,B). Side by side, he is leading the nationwide Biosafety and Biosecurity (BSBS) program, as well. He is leading strengthening AMR laboratory capacity program under the First Fleming Fund Country Grant to Bangladesh. He is also the lead for “Qualifying Workforce for AMR Surveillance in Asia and Africa” in Bangladesh. He is the initiator of the BSBS program in Bangladesh and working for strengthening country status. He has been working for ISO 15189 accreditation of Clinical Laboratory Services at ICDDR,B since 2010, and solely contributing to ISO 15190 accreditation of the same since 2016. He is a member of the ISO Biorisk Management working group ISO/TC 212/WG5 representing IFBA. He is the Chairman and Coordinator of Training of BBBS and President of the FABA. Furthermore, he is the EXCO member of A-PBA for 2024 to represent Bangladesh. He was a Member of the Board of Directors of IFBA until September 2020. Currently, he is a member of the ABSA International Engagement Committee.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.
Saturday, October 25, 2025, 1:00 PM – 5:00 PM
12. Integrating Cyberbiosecurity into Laboratory Biosecurity Programs: Addressing Emerging Threats in the Digital Age
As laboratories adopt AI, digital data systems, and networked instruments, cyberbiosecurity—the intersection of cybersecurity and biosecurity—has become vital. This interactive course introduces cyberbiosecurity as an essential discipline, equipping attendees with the knowledge and strategies to safeguard laboratory Information and Communications Technology (ICT), Operational Technologies (OT), and data assets against evolving cyber threats. Attendees will explore the fundamentals of cyberbiosecurity by diving into key concepts such as identifing laboratory assets, mapping data, and assessing vulnerabilities. Attendees will learn how to conduct comprehensive threat and vulnerability assessments and apply these principles to reinforce biosecurity programs through structured guidance and practical activities. As cyber threats continue to evolve, biosecurity programs must stay agile—capable of identifying, mitigating, and recovering from cyberattacks. This course presents strategies for strengthening cyberbiosecurity resilience through a collaborative, multidisciplinary approach that blends technical skills, professional roles, and oversight responsibilities. Through interactive activities, group discussions, and mapping exercises, participants will evaluate real-world risks and co-develop tailored solutions for laboratory settings. At the end of the course, attendees will be equipped with practical tools to embed cyberbiosecurity into their biosecurity frameworks, ensuring their labs remain secure and adaptable in a dynamic threat environment.
Objectives:
- Define and identify laboratory cyberbiosecurity assets, threats, vulnerabilities, and risks
- Apply threat and vulnerability assessment techniques and develop risk mitigation strategies to enhance laboratory resilience
- Develop a team-based approach to cyberbiosecurity management as an emerging critical component of an overall biosecurity program
Suggested Background: None
Target Audience: Laboratory Workers, All Safety Professionals
Audience Level: Basic
COURSE FACULTY
Drew Fayram is a Senior Scientist in Biosafety and Biosecurity for Merrick & Company. He consults on international and domestic projects related to laboratory planning, design, operations, biosafety, and biosecurity. Drew’s expertise includes containment laboratory operations and program management, public health laboratory testing, biosafety, biosecurity, and training. He currently serves on the Biosafety and Biosecurity Committee for the Association of Public Health Laboratories (APHL) and is an instructor for ABSA International’s Principles and Practices of Biosafety (PPB) course. Drew holds the Certified Biological Safety Professional (CBSP) and Registered Biosafety Professional (RBP) credentials through ABSA International and is registered as a biosafety officer (RBSO) with the Canadian Association for Biological Safety.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.
Sunday, October 26, 2025, 8:00 AM – 12:00 PM
18. Flipping the Table: Effective Tabletop Exercise Design and Execution
Tabletop exercises (TTXs) are an essential part of a biosafety professional’s toolkit. It offers a safe, efficient way to “stress test” the resilience of an organization’s protocols in the face of hypothetical worse-case scenarios, making them particularly valuable for reinforcing staff training, enhancing coordination and communication between teams and team members, and identifying opportunities to improve plans and procedures. Additionally, TTXs can be used to help develop new processes and procedures in support of the stand up or expansion of activities, serving as a platform for identifying critical supporting processes and procedures that need to be in place for the activity to be completed effectively. The effectiveness of tabletop exercises (TTXs) in identifying areas for improvement can be undermined by poor planning, weak execution, and insufficient follow-up. In this course, attendees will develop an understanding of when and why they should consider conducting a TTX, participate in the development of a mock exercise, and propose appropriate follow-up actions to their exercise.
Objectives:
- Identify when, why, and what type of TTX would be useful to achieve a specific outcome
- Analyze the effort needed to design and conduct an effective TTX
- Describe appropriate follow-up actions to a TTX that ensure the continual improvement of the process or program test
Suggested Background: None
Target Audience: New Biosafety Professionals, All Safety Professionals
Audience Level: Basic
COURSE FACULTY
Dr. Sharon Altmann is a Capability Manager II/Principal Scientist supporting biosafety and global engagement as part of the Integrated Health, Surveillance, and Diagnostics unit at MRIGlobal. She received her PhD in Microbiology from the University of Wisconsin—Madison, completed a postdoctoral fellowship at the National Institutes of Health-National Institute of Allergy and Infectious Diseases, and currently holds both RBP and CBSP credentials from ABSA International. With MRIGlobal, Dr. Altmann has supported multiple international engagements, including BSL-3 laboratory training in Kazakhstan; Ebolavirus outbreak response and survivor study activities; laboratory design and capacity building efforts in West Africa; BSL-4 facility standup and core laboratory support; pandemic-related return-to-work planning for schools and businesses; CLIA laboratory stand-up and operations; and biorisk management training program development for multiple clients. Dr. Altmann currently serves as a Councilor for the Chesapeake Area Biological Safety Association (ChABSA).
Scott Shearrer is a Senior Engineer and technical lead in the biosafety and global engagement team at MRIGlobal. He has over 25 years’ experience working in biosafety and biocontainment facilities overseeing the operations of BSL-4, BSL-3, ABSL-3 and BSL-2 laboratories. Mr. Shearrer has a degree in mechanical engineering and holds an RBP from ABSA International. Mr. Shearrer has supported multiple international engagements: First with a 2 year deployment to Kazakhstan providing technical assistance for the completion of two high containment laboratories, and second, assisting with operational support of mobile diagnostic laboratories in West Africa. Mr. Shearrer has previously been an ABSA course instructor on “Responding to Emergencies in Biosafety Laboratories” and has presented at multiple ABSA International-sponsored conferences. He is a current member of ABSA International’s International Engagement Committee.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.
Sunday, October 26, 2025, 1:00 PM – 5:00 PM
19. Boots on the Ground: Developing Field Laboratories in Resource-Limited Settings
This course provides attendees with the knowledge and practical skills needed to conduct research and clinical trials in international settings. It covers key aspects of fieldwork, including ethical considerations, cultural competency, regulatory requirements, data collection methods, and logistical challenges. Attendees will explore case studies and participate in hands-on training to develop strategies for navigating diverse healthcare environments, working with local stakeholders, and ensuring compliance with global research standards. Attendees will conclude the course equipped to design and implement field research projects in international contexts, addressing real-world health challenges while upholding scientific integrity and ethical responsibility.
Objectives:
- Design and Plan Fieldwork—Create a research or clinical trial protocol that includes logistics, site selection, stakeholder collaboration, and risk mitigation
- Manage Challenges in Global Research—Identify and develop solutions for common challenges such as regulatory approvals, weather emergencies, infrastructure limitations, and data security
- Implement Data Collection Methods—Utilize appropriate qualitative and quantitative data collection techniques suited for international and resource-limited settings
Suggested Background: None
Target Audience Laboratory Workers, All Safety Professionals
Audience Level: Basic
COURSE FACULTY
Krystle Hensley is the BSL4 Manager at the National Bio and Agro-Defense Facility (NBAF), a critical facility within the Agricultural Research Service of the USDA. In this role, she helps facilitate the standup of the BSL4 program and maximum containment research related to zoonotic and emerging diseases and agricultural threats. Prior to joining NBAF she worked at the Integrated Research Facility – NIAID supporting international programs and clinical trials, as well as establishing laboratory capacity in West Africa. She holds a Master of Public Health and Tropical Medicine from Tulane University and has experience in BSL3 and BSL4 research laboratories. Krystle is dedicated to advancing knowledge and contributing to cutting-edge scientific efforts to protect against emerging infectious diseases and biological threats.
Dr. Gene Olinger is Professor of Microbiology & Immunology and Director of the Galveston National Laboratory (GNL) at UTMB, one of the largest maximum containment laboratories in the United States. A leading expert in biosafety and biosecurity, Dr. Olinger brings extensive experience in the safe operation and oversight of high- and maximum containment laboratories. He is ISO 35001 and ISO 9001 Lead Auditor trained, with a strong focus on biorisk management systems and quality assurance. Throughout his career, he has led multidisciplinary teams in developing and implementing biosafety practices that support research on high-consequence pathogens. As GNL Director, he continues to advance international standards for biosafety and biosecurity while fostering global collaborations to strengthen preparedness and response to infectious disease threats.
Dr. Chad E. Mire serves as the NBAF Research Leader for the Foreign Anthropod-Borne Animal Diseases Research Unit under the United States Department of Agriculture (USDA). Prior to joining the USDA, Dr. Mire has worked at the University of Texas Medical Branch Department of Microbiology and Immunology (UTMB) for nearly a decade. Here, Dr. Mire took on several positions including Associate Professor and High-Containment Program Coordinator for Animal Research. As an Associate Professor, Dr. Mire developed research ideas in diagnostics, animal model development, vaccine, and therapeutic development in relation to emerging and zoonotic pathogens such as Ebola virus, Marburg virus, and Nipah virus. Dr. Mire received his Bachelor of Science in Biology from Rowan University, followed by receiving his Doctorate in Molecular Sciences with a focus on Virology from the University of Tennessee Health Science Center. In addition to his educational and employment history, Dr. Mire has been internationally recognized for performing leading research on emerging pathogens to develop preventative measures against emerging and zoonotic pathogens.
Dr. Lisa Hensley serves as the research leader for the Zoonotic and Emerging Disease Research Unit, or ZEDRU, located at the National Bio and Agro-Defense Facility (NBAF), which is operated by the U.S. Department of Agriculture (USDA). Dr. Hensley’s team at NBAF focus research efforts on zoonotic and emerging pathogens in large livestock and look for ways to interrupt or stop diseases, which is something USDA scientists cannot do anywhere else in the U.S. at the highest level of biocontainment or BSL-4.Before joining the USDA team at NBAF, Dr. Hensley served as the associate director for science at the National Institutes of Health’s Integrated Research Facility in Frederick, Maryland, where she was responsible for developing and managing a multidiscipline/multifaceted research portfolio supporting biodefense, potential pandemic pathogens, and emerging infectious disease research.Dr. Hensley also served as the director of regulatory science for the Medical Countermeasures Initiative in the Office of the Commissioner at the Food and Drug Administration and was the chief of Viral Therapeutics at the U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID). She has an extensive background in public health, obtaining her doctorate at the University of North Carolina at Chapel Hill and a master’s degree in immunology and infectious disease from The Bloomberg School of Public Health, Johns Hopkins University. She spent the last 25 years developing and characterizing animal models for high-consequence and emerging pathogens, including Ebola and Marburg, SARs, MERs, Variola, mpox (formerly monkeypox) and other viruses. She used these models to develop, evaluate and help advance candidate countermeasures, including therapeutics, post-exposure prophylaxes, vaccines, and diagnostics to improve national and global health.Beyond the confines of the maximum containment laboratory, Dr. Hensley worked in remote locations such as West and Central Africa, where she established research laboratories to respond to outbreaks and conduct clinical trials in low-resource environments. She is considered one of the world’s leading subject matter experts on emerging diseases and high-consequence pathogens. She is one of few scientists with experience in the development of medical countermeasures from discovery topre-clinical evaluation and through clinical trials. Dr. Hensley has authored over 250 peer-reviewed scientific papers and book chapters and holds multiple patents.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.
Sunday, October 26, 2025, 1:00 PM – 5:00 PM
20. No Resources? No Problem! A Dynamic Workshop for Improving Biosafety Program Visibility and Leadership Engagement
Building a holistic and comprehensive biorisk management program requires serious leadership commitment across your organization in order to drive successful mitigation strategies and compliance metrics. Biosafety Officers alone cannot develop, maintain, or continuously improve safety programs and require infrastructural support both within safety verticals as well as externally across divisions. It’s easy to lose sight of key objectives and results when faced with a mountain of operational issues, frustrated by a lack of resources, and feeling disconnected from leadership. Where do you begin when standing up a new biosafety program? What about implementing enterprise risk management solutions to mature an existing one? What are the pitfalls to avoid and how do you strategically engage leadership? This course will reinforce cornerstone pieces of biosafety program management with four highly interactive hands-on exercises to help drive solutions at your respective institutions. These exercises include leading indicator metrics, SOAR analysis, accountability and responsibility, and how to use appreciative inquiry as a tool for continuous improvement.
Objectives:
- Critique your respective biosafety program’s strengths and opportunities for improvement, both short and long term, and how to drive leadership engagement for support
- Establish a solutions-oriented approach that include leading indicator metrics based on SMART principles (specific, measurable, attainable, relevant, time-bound).
- Participate in hands-on exercises (4) and a discussion to foment tangible strategies to bring back to your institution, with a special emphasis on responsibility and accountability in safety program management
Suggested Background: None
Target Audience: All Safety Professionals, All Biosafety Professionals
Audience Level: Basic
COURSE FACULTY
AJ serves as the Global Director of Biosafety and Toxicology at FUJIFILM Diosynth Biotechnologies and is part of the global quality leadership team. In this critical role, he oversees safety operations for both patients and workers across 6 campuses spanning Europe and North America, assisting in and harmonizing hazard identification, risk assessment, risk mitigation, and risk monitoring strategies. AJ describes his role as a “safety diplomat” across the company’s operations landscape, with his core belief that a successful safety leadership position is predicated on collaborating with stakeholders across scientific, operational, quality and environmental health and safety (EHS) infrastructures, as well as both engaging and empowering leadership. Before joining FUJIFILM Diosynth Biotechnologies, AJ worked in various capacities as a biosafety and operations consultant in the Greater Boston, MA area and across the United States. He has audited, inspected, or provided gap analyses for laboratories at numerous multinational life science corporations, academic institutions, biotechnology start-ups, as well as various government agencies. He received his BS in Microbiology and Classics from the University of New Hampshire, a PhD in Biomedical Science with a concentration in Molecular Biology and Biophysics from the University of Connecticut Health Center and a MS in Clinical Toxicology through the University of Florida. AJ is a Registered Biosafety Professional with the American Biological Safety Association (ABSA International), and a member of ABSA’s Scientific Program Committee. A passionate safety advocate, AJ is active in both biosafety and toxicology professional organizations globally, and lives in the Boston, MA area.
As the Global Biosafety Officer for FUJIFILM Diosynth Biotechnologies, Colleen brings a wealth of experience and expertise in biorisk management, cell & viral gene therapy, and GMP operations. In this role, she serves as a centralized subject matter expert to assist in all aspects of contract development and manufacturing (CDMO) operations surrounding biologically derived therapeutics, specifically: new product introductions, risk assessments, training, and regulatory compliance. Colleen previously served as the Lead Biosafety Officer for Spark Therapeutics, overseeing capital investment projects like their new Gene Therapy Innovation Center, scaling their AAV commercial platform, and was a pivotal SME in the success of Luxturna®, the first ever FDA approved viral gene therapy for the treatment of inherited retinal dystrophy. Previous to this, she worked as the biosafety officer at the University of Pennsylvania where she partnered with Dr. Carl June on the first ever CAR-T Cell therapy, Kymriah®. Colleen has a B.S. in neuroscience from Penn State University, holds a Ph.D. in Neuroscience from the University of Pennsylvania, is a registered biosafety professional though the American Biological Safety Association (ABSA International), and is the chair of ABSA’s Scientific Program Committee. She currently lives in Philadelphia, PA with her husband and 7-year-old son, as well as their Boston Terrier puppy, Millie.
CONTACT HOURS
This course has been approved for 0.5 CM points toward RBP/CBSP recertification. ABSA International is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program. This course is approved for 3.5 P.A.C.E.® contact hours.